Exited position

Jeff Smith’s Elanco Animal Health Inc (ELAN) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Starboard Value LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ1 2021Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares7.83MHighest verified quarter-end share count
Quarters reported6Verified quarters with shares above zero
What happened?

Starboard Value LP first reported Elanco Animal Health Inc in Q1 2021. The reported position was increased and reduced across later filings. The latest verified relationship event shows that Starboard Value LP sold the entire position in Q3 2022, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q3 2022
Sold the entire position−5.73M shares · No shares reported at quarter-end
Q2 2022
Sold 16.9% of the position−1.17M shares · 5.73M shares remained
Filing context

Quarter-end price $19.63 · Estimated holding basis $29.40

Q1 2022
Sold 10.2% of the position−785.00K shares · 6.90M shares remained
Filing context

Quarter-end price $26.09 · Estimated holding basis $29.40

Q4 2021
Bought 5.1% more+373.84K shares · 7.69M shares reported after the change
Filing context

Quarter-end price $28.38 · Estimated holding basis $29.40

Q3 2021
Sold 3.9% of the position−295.00K shares · 7.31M shares remained
Filing context

Quarter-end price $31.89 · Estimated holding basis $29.45

Q2 2021
Sold 2.9% of the position−223.97K shares · 7.61M shares remained
Filing context

Quarter-end price $34.69 · Estimated holding basis $29.45

Portfolio importance

How important was Elanco Animal Health Inc in Starboard Value LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight2.0%Q2 2022
Last reported rank#16of 182 reported positions
Peak portfolio weight5.2%Q2 2021
Best historical rank#9Q1 2021
At peak importanceQ2 2021
ELAN
5.2%
Largest holding
9.2%
Cross-investor discovery

Who else owns Elanco Animal Health Inc?

Also reported by 2 other tracked investors in their latest verified filings.

Joel GreenblattGotham Asset Management
ELAN0.0% of reported portfolio
Ray DalioBridgewater Associates, LP
ELAN0.0% of reported portfolio
Explore Elanco Animal Health Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$23.002026-09-15

Market context only; not an investor transaction price.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Starboard Value LP’s Form 13F disclosures—not Jeff Smith’s personal brokerage account. Form 13F reports quarter-end U.S.-listed positions and certain options, but it does not reveal exact trade dates, execution prices, short positions or the purpose of an option position.